NOVARTIS SYMPOSIUM - REIMAGINING THE TREATMENT OF PROSTATE AND BREAST CANCERS: OUR COMMITMENT TO THE MOST COMMON CANCERS IN MEN AND WOMEN IN PORTUGAL
DATE: 13-11-2024
TIME: 12:30 / 13:30
DURATION: 1 hour and 0 minutos
LOCATION: Room B
MCRPC: RADIOLIGAND THERAPY - THE EXPERIENCE WITH 177 LU-PSMA-617
ADVANCED HR+/HER2- BREAST CANCER: ‘RIGHTCHOICE’ STUDY OF RIBOCICLIB IN AGGRESSIVE DISEASE